Martin Babler's Net Worth

$9.35 Million

Estimate Recalculated Apr 23, 2024 03:02PM EST

Who is Martin Babler?

Martin Babler has an estimated net worth of $9.35 Million. This is based on reported shares across multiple companies, which include ZS Pharma, Inc., Prelude Therapeutics Inc, Omega Alpha SPAC, Neoleukin Therapeutics, Inc., Principia Biopharma Inc., and INFINITY PHARMACEUTICALS, INC..

SEC CIK

Martin Babler's CIK is 0001435618

Past Insider Trading and Trends

2018 was Martin Babler's most active year for acquiring shares with 6 total transactions. Martin Babler's most active month to acquire stocks was the month of April. 2020 was Martin Babler's most active year for disposing of shares, totalling 22 transactions. Martin Babler's most active month to dispose stocks was the month of August. 2015 saw Martin Babler paying a total of $222,280.00 for 5,000 shares, this is the most they've acquired in one year. In 2020 Martin Babler cashed out on 1,152,863 shares for a total of $7,735,671.65, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZS Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.00K
$90.00
-$90,000.00
0
Dec 17
Form 4
—
0
—
—
0
Jun 18
Form 3
—
0
—
—
0
No matching records found

Prelude Therapeutics Inc (PRLD) Snapshot price: $2.92

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jul 19
Form 3
—
0
—
—
0
No matching records found

Omega Alpha SPAC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Neoleukin Therapeutics, Inc. (NLTX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
Sep 8
Form 3
—
0
—
—
0
No matching records found

Principia Biopharma Inc. No price found

President, CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-58.56K
$100.00
-$5,855,700.00
0
Sep 28
Form 4
—
0
$32.43
-$882,923.07
810
Scheduled
Jun 23
Form 4
-20.68%
-15.00K
$63.47
-$952,083.08
57.53K
Scheduled
Feb 10 - Mar 5
Form 4
-29.69%
-29.50K
$53.31
-$1,565,454.84
69.88K
Scheduled
Dec 17 - Dec 18
Form 4
—
0
—
—
0
Mar 1
Form 4
+22.31%
3.68K
—
—
20.2K
Sep 18
Form 3
—
0
—
—
0
No matching records found